Bourdon David 4

What Happened David Bourdon, CEO of LifeStance Health Group (LFST), had equity awards vest on March 9, 2026. The Form 4 reports two award/acquisition entries totaling 328,544 shares (awarded at $0.00 per share as vested RSUs/PSUs). To satisfy tax withholding on the net settlement, the issuer withheld 148,382 shares at an implied price of $6.91 per share, with the withheld shares valued at about $1.03 million (reported totals: $75,208; $355,685; $594,426). The withheld shares are reductions of shares issued and are not open‑market sales.

Key Details

• Transaction date: March 9, 2026; Form 4 filed March 11, 2026 (filed within the normal two‑business‑day window).
• Awards acquired: 328,544 shares (two vested PSU/RSU grants).
• Shares withheld for taxes: 148,382 shares at $6.91/share, total withheld ≈ $1,025,319.
• Net shares issued to Bourdon after withholding: 180,162 shares (328,544 − 148,382).
• Transaction codes: A = Award/Grant (vesting); F = Tax withholding (not an open‑market sale).
• Footnotes explain these were performance‑based RSUs/PSUs that vested and that withheld shares “do not constitute any open‑market sale.”

Context This was a compensation/vesting event (performance‑based RSUs/PSUs vesting), not a purchase or voluntary sale. Net settlement via share withholding to cover taxes (a common practice) reduces the number of shares actually delivered to the insider and should not be read as a bearish sale. The filing appears timely and does not indicate a 10% owner or a 10b5‑1 plan.